Toronto Immune & Digestive Health Institute ( Site 0005)

Toronto, Ontario M6A 3B4

1 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) — Recruiting now
• A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) — Running, not enrolling